COMMUNIQUÉS West-GlobeNewswire

EUROBIO SCIENTIFIC: CONCLUSION OF AN AGREEMENT BETWEEN EUROBIO SCIENTIFIC AND A CONSORTIUM LED BY EUROBIO SCIENTIFIC'S TEAM OF ENTREPRENEURS AND MANAGERS, IK PARTNERS AND NEXTSTAGE AM WITH A VIEW TO FILE A VOLUNTARY TENDER OFFER AT A PRICE

31/07/2024 - 21:03

NOT FOR DISTRIBUTION, PUBLICATION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OR TO ANY US PERSON, OR TO ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION, PUBLICATION OR RELEASE WOULD [...]

Eurobio Scientific: FIRST HALF 2024, A SOLID START TO THE FINANCIAL YEAR IN AN UNCERTAIN ENVIRONMENT // PROPOSED TENDER OFFER

31/07/2024 - 21:01

NOT FOR DISTRIBUTION, PUBLICATION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OR TO ANY US PERSON, OR TO ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION, PUBLICATION OR RELEASE WOULD [...]

Eurobio Scientific : PREMIER SEMESTRE 2024, UN SOLIDE DEBUT D’EXERCICE DANS UN CONTEXTE INCERTAIN // PROJET D’OFFRE PUBLIQUE

31/07/2024 - 21:01

NE PAS DISTRIBUER, PUBLIER OU DIFFUSER, EN TOUT OU EN PARTIE, DIRECTEMENT OU INDIRECTEMENT, AUX ETATS-UNIS OU A TOUTE PERSONNE DES ETATS-UNIS, OU DANS TOUTE AUTRE JURIDICTION DANS LAQUELLE LA DISTRIBUTION, LA [...]

ARCPOINT ANNOUNCES CLOSING OF NON-BROKERED PRIVATE PLACEMENT AND WARRANT AMENDMENTS

31/07/2024 - 20:48

Not for Dissemination in the United States or through U.S. Newswire Services Greenville, South Carolina, July 31, 2024 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “ Company ” or “ ARCpoint ”) is pleased to [...]

NeuroMetrix, Inc. Announces Date for Second Quarter 2024 Business Highlights Conference Call

31/07/2024 - 20:03

WOBURN, Mass., July 31, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2024 second quarter business and financial highlights before the opening of the market on [...]

AMN Healthcare Launches Executive Advisory Board

31/07/2024 - 19:00

Move brings experienced, accomplished health leader to help AMN address healthcare industry’s workforce challenges DALLAS, July 31, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare (NYSE: AMN) is taking steps to further [...]

Betterguards Unveils New Sports Tech, The BetterGuard 2.0

31/07/2024 - 17:26

Intelligent ankle brace technology offers preventative support against common ankle injuries NEW YORK, July 31, 2024 (GLOBE NEWSWIRE) -- Betterguards , a next-generation sports technology innovator, announces the launch [...]

20 Facilities Ranked as the 2024 Most Beautiful Hospitals in the U.S.

31/07/2024 - 16:00

Hospitals chosen for their exceptional facilities, staff and patient experience in contest hosted by national staffing firm Soliant ATLANTA, July 31, 2024 (GLOBE NEWSWIRE) -- National staffing firm Soliant today named [...]

BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation

31/07/2024 - 15:45

Los Angeles, July 31, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM) (“BioSig” or “Company”), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac signal [...]

Natural Harmony Foods Inc. Completes Financial Audits for 2022 & 2023

31/07/2024 - 15:30

Unlocking Funds to Accelerate Operations NEW YORK, July 31, 2024 (GLOBE NEWSWIRE) -- Publicly-held Natural Harmony Foods Inc. (OTC: NHYF) is delighted to report the completion of its financial statement audits for the [...]

Palisade Bio Participates in Virtual Investor “What this Means” Segment

31/07/2024 - 15:15

Mitch Jones, MD, PhD, CMO of Palisade Bio highlights recent findings from a microbiome study confirming local bioactivation of lead product candidate, PALI-2108 Carlsbad, CA, July 31, 2024 (GLOBE NEWSWIRE) -- Palisade [...]

Rhythm Pharmaceuticals Announces European Commission Expands ▼IMCIVREE® (setmelanotide) Marketing Authorization to include Children as Young as 2 Years Old

31/07/2024 - 15:10

IMCIVREE now authorized as treatment of obesity and control of hunger in adult patients and pediatric patients 2 years old or older with Bardet Biedl syndrome or POMC, PCSK1, or LEPR deficiency BOSTON, July 31, 2024 ( [...]

Arch Biopartners Closes Non-Brokered Private Placement

30/07/2024 - 22:47

TORONTO, July 30, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has closed the non-brokered private placement disclosed in a press [...]

TRACON Pharmaceuticals Announces it Will Wind Down Operations

30/07/2024 - 22:44

SAN DIEGO, July 30, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (OTCQB: TCON) today announced that the Company has terminated its employees and will wind down its operations. This decision was made at a special [...]

DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results

30/07/2024 - 22:30

Châtillon, France, July 30, 2024 DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results VITESSE enrollment in peanut [...]

DBV Technologies présente les dernières avancées du programme Viaskin Peanut chez les enfants de 4 à 7 ans et les tout-petits de 1 à 3 ans et publie ses résultats financiers du deuxième trimestre et premier semestre 2024.

30/07/2024 - 22:30

DBV Technologies présente les dernières avancées du programme Viaskin Peanut chez les enfants de 4 à 7 ans et les tout-petits de 1 à 3 ans et publie ses résultats financiers du deuxième trimestre et premier semestre [...]

MannKind Corporation to Hold 2024 Second Quarter Financial Results Conference Call on August 7, 2024

30/07/2024 - 22:30

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , announced today that it will report its second quarter 2024 financial results before the market opens [...]

Panbela to Host Second Quarter 2024 Earnings Conference Call on Aug 13, 2024

30/07/2024 - 22:15

MINNEAPOLIS, July 30, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), (“Panbela”), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical [...]

MacroGenics Provides Vobramitamab Duocarmazine Update

30/07/2024 - 22:10

Abstract of clinical data accepted for poster presentation at ESMO Congress 2024 in September ESMO poster to include protocol-defined TAMARACK Phase 2 mCRPC study data, including pre-defined landmark primary endpoint of [...]